Dennis Langer

Director, Myriad Genetics.

Companies

Quoin Pharmaceuticals Ltd.Board member Jan 3, 2023 to now¹
Myriad GeneticsBoard member Jan 6, 2006 to Jun 30, 2022²
Ernexa Therapeutics Inc.Board member May 5, 2021 to Dec 10, 2021³
Dicerna Pharmaceuticals (United States)Board member Jan 29, 2014 to Jun 21, 2019⁴
Pernix Therapeutics HoldingsBoard member Nov 8, 2016 to May 23, 2018⁵
Delcath Systems, Inc.Board member Dec 15, 2014 to Jun 12, 2015⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Myriad Genetics MYGN106,802 shares⁷$443.8K at $4.16Jun 30, 2022
Quoin Pharmaceuticals Ltd. QNRX56,243 shares⁸$227.8K at $4.05Aug 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 27, 2026Granted 34,534 shares at $5.15 of Quoin Pharmaceuticals Ltd.⁸
Oct 14, 2025Bought 15,152 shares at $8.49 of Quoin Pharmaceuticals Ltd.⁹
Jun 7, 2024Sold 297 shares at $0.73 of Quoin Pharmaceuticals Ltd.¹⁰
Jun 2, 2022Granted 17,275 shares of Myriad Genetics¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARQuoin Pharmaceuticals Ltd., Board member
2
SEC EDGARMyriad Genetics, Board member
3
SEC EDGARErnexa Therapeutics Inc., Board member
4
SEC EDGARDicerna Pharmaceuticals (United States), Board member
5
SEC EDGARPernix Therapeutics Holdings, Board member
6
SEC EDGARDelcath Systems, Inc., Board member
7
SEC EDGARMyriad Genetics shares after the filing of Jun 30, 2022
8
SEC EDGARQuoin Pharmaceuticals Ltd. shares after the filing of Aug 27, 2026
9
SEC EDGARForm 4 filed Oct 15, 2025
10
SEC EDGARForm 4 filed Jun 10, 2024
11
SEC EDGARForm 4 filed Jun 3, 2022